ES2496946T3 - Derivados de nucleótidos de purina - Google Patents

Derivados de nucleótidos de purina Download PDF

Info

Publication number
ES2496946T3
ES2496946T3 ES05755520.3T ES05755520T ES2496946T3 ES 2496946 T3 ES2496946 T3 ES 2496946T3 ES 05755520 T ES05755520 T ES 05755520T ES 2496946 T3 ES2496946 T3 ES 2496946T3
Authority
ES
Spain
Prior art keywords
cyclic
mmol
adenosine
nmr
ampsc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05755520.3T
Other languages
English (en)
Spanish (es)
Inventor
Kjell Undheim
Kjetil TASKÉN
Jo Klaveness
Geir Langli
Vidar BJØRNSTAD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvell AS
Original Assignee
Solvell AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvell AS filed Critical Solvell AS
Application granted granted Critical
Publication of ES2496946T3 publication Critical patent/ES2496946T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ES05755520.3T 2004-06-18 2005-06-20 Derivados de nucleótidos de purina Expired - Lifetime ES2496946T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0413726 2004-06-18
GBGB0413726.1A GB0413726D0 (en) 2004-06-18 2004-06-18 Compounds
PCT/GB2005/002418 WO2005123755A2 (en) 2004-06-18 2005-06-20 Purine nucleotide derivatives

Publications (1)

Publication Number Publication Date
ES2496946T3 true ES2496946T3 (es) 2014-09-22

Family

ID=32750205

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05755520.3T Expired - Lifetime ES2496946T3 (es) 2004-06-18 2005-06-20 Derivados de nucleótidos de purina

Country Status (10)

Country Link
US (1) US8153609B2 (https=)
EP (1) EP1765844B1 (https=)
JP (1) JP5044750B2 (https=)
CN (1) CN101001865A (https=)
AU (1) AU2005254790B2 (https=)
CA (1) CA2568907C (https=)
DK (1) DK1765844T3 (https=)
ES (1) ES2496946T3 (https=)
GB (1) GB0413726D0 (https=)
WO (1) WO2005123755A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007006544A2 (en) * 2005-07-12 2007-01-18 Vrije Universiteit Brussel Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
GB0618235D0 (en) * 2006-09-15 2006-10-25 Lauras As Process
LT2448968T (lt) * 2009-06-29 2021-05-10 Bioarctic Ab Antikūnai, atpažįstantys n gale sutrumpintas amiloido protofibriles/oligomerus
NZ607996A (en) 2010-09-22 2014-07-25 Alios Biopharma Inc Substituted nucleotide analogs
CA2819041A1 (en) * 2010-12-22 2012-06-28 Alios Biopharma, Inc. Cyclic nucleotide analogs
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
SG10201913554YA (en) 2011-12-22 2020-03-30 Alios Biopharma Inc Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
HK1206362A1 (zh) 2012-03-21 2016-01-08 Alios Biopharma, Inc. 硫代氨基磷酸酯核苷酸前藥的固體形式
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
US20240182511A1 (en) * 2021-04-09 2024-06-06 Merck Sharp & Dohme Llc Novel forms of cyclic dinucleotide compounds
CN117999269A (zh) 2021-09-06 2024-05-07 米雷卡医药有限公司 用于生产环状鸟苷-单磷酸酯类似物的改进方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968101A (en) * 1974-12-20 1976-07-06 Icn Pharmaceuticals, Inc. 8-Substituted cyclic nucleotides by free radical alkylation and acylation
WO1989007108A1 (en) 1988-02-01 1989-08-10 Bernd Jastorff Process for producing nucleoside-3',5'-cyclophosphates and nucleoside-3',5'-cyclothiophosphates
WO1993021929A1 (en) 1992-05-01 1993-11-11 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Phosphorothioate derivatives of cyclic amp analogues
US5625056A (en) * 1992-05-26 1997-04-29 Biolog Life Science Institute Derivatives of cyclic guanosine-3',5'-monophosphorothioate
NO971997D0 (no) 1997-04-29 1997-04-29 Kjetil Tasken Bruk av immunmodulerende midler
JP4902958B2 (ja) * 2002-06-07 2012-03-21 ユニバーシテール・メディッシュ・セントラム・ユトレヒト ｃＡＭＰによって直接活性化される交換タンパク質（Ｅｐａｃ）の活性をモジュレートするための新規な化合物

Also Published As

Publication number Publication date
GB0413726D0 (en) 2004-07-21
CN101001865A (zh) 2007-07-18
DK1765844T3 (da) 2014-09-01
EP1765844A2 (en) 2007-03-28
JP5044750B2 (ja) 2012-10-10
AU2005254790B2 (en) 2012-02-23
EP1765844B1 (en) 2014-07-30
US8153609B2 (en) 2012-04-10
WO2005123755A3 (en) 2006-04-06
JP2008502673A (ja) 2008-01-31
AU2005254790A1 (en) 2005-12-29
US20080293665A1 (en) 2008-11-27
CA2568907C (en) 2015-06-09
CA2568907A1 (en) 2005-12-29
WO2005123755A2 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
JP7158428B2 (ja) リボシドの調製のための方法
CA2828326C (en) Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the treatment of cancer
EP2609923B1 (en) Process for the crystallisation of (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
KR102363946B1 (ko) HCV 치료를 위한 β-D-2'-데옥시-2'-α-플루오로-2'-β-C-치환된-2-변형된-N6-치환된 퓨린 뉴클레오티드
JP6646668B2 (ja) 抗がん性化合物としての新規な２’および／または５’アミノ酸エステルホスホロアミダート３’−デオキシアデノシン誘導体
ES2496946T3 (es) Derivados de nucleótidos de purina
US20100137576A1 (en) 5' o [(n acyl)amidophosphate] and 5' o [(n acyl)amidothiophosphate] and 5' o [(n acyl)amidodithiophosphate] and 5' o [(n acyl)amidoselenophosphate] derivatives of nucleosides and processes for the manufacture thereof
KR20030022295A (ko) 포스포네이트 뉴클레오티드 유사체의 전구약물과 그것의선택 및 제조 방법
KR20060008297A (ko) 2'-데옥시-β-Ｌ-뉴클레오시드의 제조방법
WO2021098379A1 (zh) 苯丙氨酸酰胺化的核苷酸衍生物及其制备方法与应用
EP3820879B1 (en) Phosphorus-containing prodrugs of gemcitabine
Piperno et al. Recent highlights in the synthesis of anti-HCV ribonucleosides
CN1812995A (zh) 工业化规模的核苷合成
CN111836823A (zh) β修饰磷酸化合物前体、β修饰磷酸化合物、反应阻碍剂和包含这些化合物的医药品以及反应阻碍方法
EP0799834A1 (en) Modified nucleotides
JPH11279193A (ja) アデノシン誘導体
SM Miranda et al. The Chemistry of Anti-HCV Nucleosides and Pro-Nucleotides
Perlíková Synthesis of novel cytostatic deazapurine nucleosides and pronucleotides
Giofrè et al. Phosphonated isoxazolidinyl nucleosides, a new class of modified nucleosides
HK1182938B (en) Process for the crystallisation of (s)-isopropyl 2-(((s)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate
TW201210602A (en) Phosphorus-containing prodrugs and their therapeutic use